未找到相关数据
RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM).
被引：48
作者：
Gilbert, M. R.
Wang, M.
Aldape, K. D.
Stupp, R.
Hegi, M.
Jaeckle, K. A.
Armstrong, T. S.
Wefel, J. S.
Won, M.
Blumenthal, D. T.
Mahajan, A.
Schultz, C. J.
Erridge, S. C.
Brown, P. D.
Chakravarti, A.
Curran, W. J.
Mehta, M. P.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Radiat Therapy Oncol Grp, Philadelphia, PA USA
[3] Univ Lausanne Hosp CHUV, Lausanne, Switzerland
[4] Mayo Clin, Jacksonville, FL 32224 USA
[5] Univ Texas Hlth Sci Ctr Houston, Sch Nursing, Houston, TX 77030 USA
[6] RTOG, Philadelphia, PA USA
[7] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
[8] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[9] Univ Edinbugh, Edinburgh, Midlothian, Scotland
[10] Ohio State Univ, Med Ctr, Arthur G James Canc Hosp, Columbus, OH 43210 USA
[11] Radiat Therapy Oncol Grp, Atlanta, GA USA
[12] Emory Univ, Atlanta, GA 30322 USA
[13] Northwestern Univ, Chicago, IL 60611 USA
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.2006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2006
引用
收藏
页数：1
相关论文